Whitfield, Tim ORCID: 0000-0002-0305-646X, Demnitz-King, Harriet, Schlosser, Marco ORCID: 0000-0002-0634-0749, Barnhofer, Thorsten, Frison, Eric ORCID: 0000-0001-5844-1886, Coll-Padros, Nina ORCID: 0000-0002-9282-6701, Dautricourt, Sophie, Requier, Florence, Delarue, Marion, Gonneaud, Julie ORCID: 0000-0003-0566-5581, Klimecki, Olga M., Lutz, Antoine, Paly, Leo, Salmon, Eric, Schild, Ann-Katrin ORCID: 0000-0002-1920-0198, Walker, Zuzana, Jessen, Frank, Chetelat, Gael, Collette, Fabienne, Wirth, Miranka and Marchant, Natalie L. (2022). Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. Alzheimers Res. Ther., 14 (1). LONDON: BMC. ISSN 1758-9193

Full text not available from this repository.

Abstract

Background Older individuals with subjective cognitive decline (SCD) perceive that their cognition has declined but do not show objective impairment on neuropsychological tests. Individuals with SCD are at elevated risk of objective cognitive decline and incident dementia. Non-pharmacological interventions (including mindfulness-based and health self-management approaches) are a potential strategy to maintain or improve cognition in SCD, which may ultimately reduce dementia risk. Methods This study utilized data from the SCD-Well randomized controlled trial. One hundred forty-seven older adults with SCD (M-Age = 72.7 years; 64% female) were recruited from memory clinics in four European countries and randomized to one of two group-based, 8-week interventions: a Caring Mindfulness-based Approach for Seniors (CMBAS) or a health self-management program (HSMP). Participants were assessed at baseline, post-intervention (week 8), and at 6-month follow-up (week 24) using a range of cognitive tests. From these tests, three composites were derived-an abridged Preclinical Alzheimer's Cognitive Composite 5 (PACC5(Abridged)), an attention composite, and an executive function composite. Both per-protocol and intention-to-treat analyses were performed. Linear mixed models evaluated the change in outcomes between and within arms and adjusted for covariates and cognitive retest effects. Sensitivity models repeated the per-protocol analyses for participants who attended >= 4 intervention sessions. Results Across all cognitive composites, there were no significant time-by-trial arm interactions and no measurable cognitive retest effects; sensitivity analyses supported these results. Improvements, however, were observed within both trial arms on the PACC5(Abridged) from baseline to follow-up (Delta [95% confidence interval]: CMBAS = 0.34 [0.19, 0.48]; HSMP = 0.30 [0.15, 0.44]). There was weaker evidence of an improvement in attention but no effects on executive function. Conclusions Two non-pharmacological interventions conferred small, non-differing improvements to a global cognitive composite sensitive to amyloid-beta-related decline. There was weaker evidence of an effect on attention, and no evidence of an effect on executive function. Importantly, observed improvements were maintained beyond the end of the interventions. Improving cognition is an important step toward dementia prevention, and future research is needed to delineate the mechanisms of action of these interventions and to utilize clinical endpoints (i.e., progression to mild cognitive impairment or dementia).

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Whitfield, TimUNSPECIFIEDorcid.org/0000-0002-0305-646XUNSPECIFIED
Demnitz-King, HarrietUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schlosser, MarcoUNSPECIFIEDorcid.org/0000-0002-0634-0749UNSPECIFIED
Barnhofer, ThorstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Frison, EricUNSPECIFIEDorcid.org/0000-0001-5844-1886UNSPECIFIED
Coll-Padros, NinaUNSPECIFIEDorcid.org/0000-0002-9282-6701UNSPECIFIED
Dautricourt, SophieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Requier, FlorenceUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Delarue, MarionUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gonneaud, JulieUNSPECIFIEDorcid.org/0000-0003-0566-5581UNSPECIFIED
Klimecki, Olga M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lutz, AntoineUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Paly, LeoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Salmon, EricUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schild, Ann-KatrinUNSPECIFIEDorcid.org/0000-0002-1920-0198UNSPECIFIED
Walker, ZuzanaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jessen, FrankUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chetelat, GaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Collette, FabienneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wirth, MirankaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Marchant, Natalie L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-695529
DOI: 10.1186/s13195-022-01057-w
Journal or Publication Title: Alzheimers Res. Ther.
Volume: 14
Number: 1
Date: 2022
Publisher: BMC
Place of Publication: LONDON
ISSN: 1758-9193
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
STRESS REDUCTION; IMPAIRMENT; MEDITATION; COMPLAINTS; DEMENTIA; THERAPY; PROGRAM; IMPACTMultiple languages
Clinical Neurology; NeurosciencesMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/69552

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item